The global bio fund centering women founders and customers to drive equity and returns

Ipshita Mandal-Johnson was raised in India and says growing up in an unequal society helped her overcome limitations. With a new life sciences fund, Mandal-Johnson is again going beyond what has historically been possible. Mandal-Johnson and co-founder Giorgio Reggiani are investing their Global Bio Fund exclusively in women-led bio startups with solutions in health and wellbeing, food and agriculture and energy and environment. Women-led companies generate more revenue with less capital and return a higher investment rate of return than male-founded firms